Search results
Study: American workers plan to slow-roll into retirement
New Hampshire Union Leader· 13 hours agoSay goodbye to the big retirement party and gold watch presentation. As more workers plan to delay...
Q1 2024 Cellectar Biosciences Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 41 minutes agoI am pleased to report that we remain on track for a Q2 data announcement for the fully enrolled study patient population. We plan to press release this ...
Interviews for Onsted schools superintendent finalists to wrap up this week
The Daily Telegram via Yahoo News· 38 minutes agoThe second-round interviews have been scheduled for one hour for each candidate. The interviews...
Science missions to Mars - NASA starts commercial service studies
Electronics Weekly· 3 hours agoTo enable science missions to Mars, NASA has selected nine U.S. companies to perform initial studies...
Raleigh traffic study looked at improvements needed to handle ongoing population boom
WTVD-TV 11 Raleigh-Durham· 10 hours agoArea Metropolitan Planning Organization (CAMPO) staff met again Tuesday with Raleigh City Council to...
Springfield High School student plans to study neuroscience at Harvard, inspired by his brother
CBS News· 1 day agoA Springfield High School senior is making history. Emmanuel Gitu was accepted to a total of 31...
Point Reyes seashore study favors elk fence removal
San Jose Mercury News· 20 hours agoA new study suggests a plan to remove a controversial fence to free tule elk in the Point Reyes National Seashore would achieve the park’s preservation...
Earnings call: Atea Pharmaceuticals reports progress in COVID-19 trial
Investing.com· 3 hours agoAtea Pharmaceuticals, a biopharmaceutical company focused on developing therapeutics for viral...
Tenon Medical Inc (TNON) Q1 2024 Earnings Call Transcript Highli
Guru Focus· 17 minutes agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. The company has a strong patent portfolio with 8 issued patents and 23 pending applications ...
Acumen Pharmaceuticals Inc (ABOS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
GuruFocus.com via Yahoo Finance· 1 hour agoA: (Eric Siemers, Chief Medical Officer) While theoretically possible, logistically integrating the subcutaneous formulation into the ALTITUDE study would be challenging.